Article info
PDFResearch ethics
Paper
Non-completion and informed consent
- Correspondence to Dr Alan Wertheimer, Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, MD 02892, USA; wertheimera{at}cc.nih.gov
Citation
Non-completion and informed consent
Publication history
- Received September 20, 2012
- Revised January 7, 2013
- Accepted January 8, 2013
- First published January 31, 2013.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis
- Systematic review and metasummary of attitudes toward research in emergency medical conditions
- Assessing research risks systematically: the net risks test
- Phase 1 oncology trials and informed consent
- Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?
- CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
- Participants’ responsibilities in clinical research
- Risk factors associated with Richter’s transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study
- Phase I oncology trials: why the therapeutic misconception will not go away
- Therapeutic appropriation: a new concept in the ethics of clinical research